Medicines
Discover all available medicines and treatments
Discover all available medicines and treatments
Brand: Alupent, Metaprel
Metaproterenol is a short-acting beta-2 adrenergic agonist used to treat asthma and other respiratory conditions like bronchitis and emphysema. It works by relaxing the smooth muscles in the airways, allowing them to open up and making it easier to breathe. It belongs to the class of bronchodilators.
For the relief of bronchospasm in acute and chronic asthma, bronchitis, and emphysema.
Outcome:
Reduced bronchodilator effect, possible bronchospasm.
Mechanism:
Beta-blockers antagonize the effects of beta-2 agonists.
Outcome:
Increased risk of adverse effects such as tremors and palpitations.
Mechanism:
Additive effects on the central nervous system and cardiovascular system.
Outcome:
May slightly decrease absorption of metaproterenol.
Mechanism:
Changes in gastric pH.
Most likely new formulation: Extended-release oral formulation (2025, 30% confidence)
Based on declining usage trends and the availability of newer, more selective beta-2 agonists, there is a 20% likelihood of metaproterenol being phased out in some markets over the next 10 years.
Bronchodilator, Beta-2 Adrenergic Agonist
Resorcinol